ATRA - Biotech Bonanza: The Mergers And Acquisitions Theme
Biotech Pulse
Biotech tumbled off a steep ski slope in the last quarter, and at the December low, the Nasdaq Biotechnology Index (IBB) had declined -28%, while the S&P Biotech Select Index (XBI) a whopping -36%. But it seems biotechs were able to regain their composure at the lows and ski gracefully higher during January in what now appears to have been a V-shaped two-month ride. Most likely, the pace of sharp run-up will now moderate out as it has offset the panic selling during December. In addition, the growing presence